Operator Hello, and welcome to the fourth quarter and full year 2024 Teva Pharmaceutical Industries earnings conference call.

Shares of Teva Pharmaceutical Industries ( TEVA -13.66%) were slipping Wednesday. The company's stock lost 13.5% as of 1:15 p ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

The pharmaceutical industry is experiencing an exciting transformation, shifting from transactional partnerships to strategic ...

Requiring price disclosures on advertisements for prescription drugs would empower patients and reduce excess spending on ...

Sun Pharmaceutical Industries Ltd. closed 11.40% below its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

Three senators who displayed some of the most hostility towards Health and Human Services secretary nominee Robert F. Kennedy ...

Barclays analyst Balaji Prasad maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) today and set a price target of $28.00.

The government may extend the deadline for drug manufacturers to comply with revised Schedule M standards until December 2025 ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 advanced 2.01% to 1,834.05 Indian rupees Thursday, on what proved to be ...